Sun Pharma, Dr Reddy’s, Zydus, Glenmark launch generic semaglutide
Following DCGI approval to manufacture and market the product for the treatment of diabetes and obesity, Zydus Life Sciences has launched Semaglutide Injection under the brand names Semaglin, Mashema and Ultrame. | Photo Credit: Special Arrangement Following the expiry of the patent on the active ingredient in Danish major Novo Nordisk’s blockbuster diabetes and weight … Read more